Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Prados, M. D., Chang, S. M., Butowski, N., DeBoer, R., Parvataneni, R., Carliner, H., Kabuubi, P., Ayers-Ringler, J., Rabbitt, J., Page, M., Fedoroff, A., Sneed, P. K., Berger, M. S., McDermott, M. W.Volume:
27
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2008.18.9639
Date:
December, 2008
File:
PDF, 195 KB
english, 2008